Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Uniqure stock
Learn how to easily invest in Uniqure stock.
Uniqure NV is a biotechnology business based in the US. Uniqure shares (QURE) are listed on the NASDAQ and all prices are listed in US Dollars. Uniqure employs 463 staff and has a trailing 12-month revenue of around $62 million.
How to buy shares in Uniqure
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – QURE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Uniqure stock price (NASDAQ: QURE)Use our graph to track the performance of QURE stocks over time.
Uniqure shares at a glance
|Latest market close||$19.53|
|52-week range||$12.52 - $36.55|
|50-day moving average||$20.58|
|200-day moving average||$18.38|
|Wall St. target price||$49.75|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$7.60|
Buy Uniqure shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Uniqure stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Uniqure price performance over time
|1 week (2022-09-28)||3.55%|
|1 month (2022-09-02)||-5.47%|
|3 months (2022-07-05)||-6.29%|
|6 months (2022-04-05)||-0.41%|
|1 year (2021-10-05)||-37.66%|
|2 years (2020-10-05)||-48.44%|
|3 years (2019-10-04)||42.7|
|5 years (2017-10-05)||84.07%|
Is Uniqure stock undervalued or overvalued?
Valuing Uniqure stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Uniqure's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Uniqure's P/E ratio
Uniqure's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Uniqure shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||$62 million|
|Gross profit TTM||$362.2 million|
|Return on assets TTM||-12.28%|
|Return on equity TTM||-20.37%|
|Market capitalisation||$876.6 million|
TTM: trailing 12 months
Uniqure share dividends
We're not expecting Uniqure to pay a dividend over the next 12 months.
Have Uniqure's shares ever split?
Uniqure's shares were split on a 1:5 basis on 30 January 2014. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Uniqure shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Uniqure shares which in turn could have impacted Uniqure's share price.
Uniqure share price volatility
Over the last 12 months, Uniqure's shares have ranged in value from as little as $12.52 up to $36.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Uniqure's is 1.0743. This would suggest that Uniqure's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
uniQure N. V. , a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N. V.
Uniqure in the news
uniQure to Participate in Upcoming Industry Conferences in October
uniQure to Participate in Upcoming Industry Conferences in October
uniQure to Participate in Upcoming Industry Conferences in September
Frequently asked questionsWhat percentage of Uniqure is owned by insiders or institutions?
Currently 7.018% of Uniqure shares are held by insiders and 97.757% by institutions. How many people work for Uniqure?
Latest data suggests 463 work at Uniqure. When does the fiscal year end for Uniqure?
Uniqure's fiscal year ends in December. Where is Uniqure based?
Uniqure's address is: Paasheuvelweg 25a, Amsterdam, Netherlands, 1105 BP What is Uniqure's ISIN number?
Uniqure's international securities identification number is: NL0010696654 What is Uniqure's CUSIP number?
Uniqure's Committee on Uniform Securities Identification Procedures number is: N90064101
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert